Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,438.21
(
-0.84%
)
US TECH 100
28,478.80
(
-1.09%
)
Dow Jones
49,647.58
(
-0.83%
)
Brent Oil
106.45
(
2.17%
)
Bitcoin
79,041.10
(
-2.49%
)
News Focus
News Focus
Post# of 257570
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 48
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 134528

Saturday, 01/07/2012 5:31:37 AM

Saturday, January 07, 2012 5:31:37 AM

Post# of 257570
I found this quote interesting


"I don't really have concern about the level of safety (of biosimilars)," he said. "What is a question-mark is efficacy, since many biotechnology products are now being improved."



Isn't a concern of the FDA added risk of immunogenicity?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today